These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15910566)

  • 1. Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo.
    Petersen KA; Nilsson E; Olesen J; Edvinsson L
    Cephalalgia; 2005 Jun; 25(6):424-32. PubMed ID: 15910566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats.
    Sheykhzade M; Nyborg NC
    Br J Pharmacol; 1998 Apr; 123(7):1464-70. PubMed ID: 9579744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
    Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
    Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
    Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
    J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
    Edvinsson L; Nilsson E; Jansen-Olesen I
    Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
    Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
    Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of KATP channels in the regulation of rat dura and pia artery diameter.
    Gozalov A; Petersen KA; Mortensen C; Jansen-Olesen I; Klaerke D; Olesen J
    Cephalalgia; 2005 Apr; 25(4):249-60. PubMed ID: 15773822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds.
    Nuki C; Kawasaki H; Kitamura K; Takenaga M; Kangawa K; Eto T; Wada A
    Biochem Biophys Res Commun; 1993 Oct; 196(1):245-51. PubMed ID: 8216298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats.
    Shirai M; Shimouchi A; Ikeda S; Ninomiya I; Sunagawa K; Kangawa K; Matsuo H
    Br J Pharmacol; 1997 Jun; 121(4):679-86. PubMed ID: 9208134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
    Waugh DJ; Bockman CS; Smith DD; Abel PW
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo effect of adrenomedullin on rat dural and pial arteries.
    Juhl L; Petersen KA; Larsen EH; Jansen-Olesen I; Olesen J
    Eur J Pharmacol; 2006 May; 538(1-3):101-7. PubMed ID: 16643888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat.
    Edvinsson L; Goadsby PJ; Uddman R
    ScientificWorldJournal; 2001 May; 1():168-80. PubMed ID: 12805660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca
    Erdling A; Sheykhzade M; Edvinsson L
    J Headache Pain; 2017 Dec; 18(1):61. PubMed ID: 28560541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
    Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
    Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of caffeine on cerebral blood flow response to somatosensory stimulation.
    Meno JR; Nguyen TS; Jensen EM; Alexander West G; Groysman L; Kung DK; Ngai AC; Britz GW; Winn HR
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):775-84. PubMed ID: 15703695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of amylin with calcitonin gene-related peptide receptors in the microvasculature of the hamster cheek pouch in vivo.
    Hall JM; Brain SD
    Br J Pharmacol; 1999 Jan; 126(1):280-4. PubMed ID: 10051146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs.
    Baskaya MK; Suzuki Y; Anzai M; Seki Y; Saito K; Takayasu M; Shibuya M; Sugita K
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):827-34. PubMed ID: 7673375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
    Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.